Skip to main content
. 2021 Dec 19;12(2):12274–12293. doi: 10.1080/21655979.2021.2006966

Figure 7.

Figure 7.

GO analysis for luteolin anti-inflammatory targets. (a) 6 luteolin anti-inflammatory targets enriched of CC items; (b) 2 luteolin anti-inflammatory targets enriched of MF items; (c) 3 luteolin anti-inflammatory targets enriched of BP items. (P value < 0.05 for GO enrichment were considered statistically significant)